CLINICAL_TRIALS
trial_result
· 2017-01-06
Clinical Trial Update: Safety and Immunogenicity of a Candidate Tuberculosis (TB) Vaccine in HIV-positive Adults. [Phase 2]
Summary
Phase 2 trial update assessing safety and immunogenicity of a TB vaccine candidate in HIV-positive adults; results available.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: GlaxoSmithKline | Conditions: Tuberculosis | Phase 2 | Status: COMPLETED | Results posted: 2017-01-06